Colorectal Cancer Screening Outreach
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07345676
- Status
- Recruiting
Conditions
- Colo-rectal Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bundled messaging intervention — BEHAVIORALA bundled intervention of text message, letter, and provider reminder. Text message content using behaviorally motivated messages will vary.
Study Details
This is a 4 arm pragmatic trial to test a multicomponent intervention designed to improve adherence to colorectal cancer screening.
Key Dates
- First listed
- Jan 16, 2026
- Start date
- Jun 23, 2026
- Status verified
- Jul 2026
- Primary completion
- Apr 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 2,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- No Intervention: Control-Usual CareParticipants will receive a simple text message reminder
- Experimental: Messaging Group AParticipants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
- Experimental: Messaging Group BParticipants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
- Experimental: Messaging Group CParticipants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
Primary Outcome Measure
Number of participants with scheduled or completed colorectal cancer screening. [ Time Frame: up to 3 months from randomization ]
Central Contacts
- Ilana Richman, MD203 737 1024
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cornell Scott Hill Health | New Haven | Connecticut | 06519 | - |
Find similar trials in New Haven, CT
By research site
Related Studies
- Shield Post-Approval Study ProtocolRecruiting · Guardant Health, Inc. · Chandler, Arizona
- Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal SurgeryRecruiting · University of California, Davis · Sacramento, California
- Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot StudyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialPHASE3 · Recruiting · Roswell Park Cancer Institute · Buffalo, New York